“Aprepitant, a novel neurokinin-1 receptor antagonist in management of chemotherapy induces nausea vomiting (CINV) in cancer patients”, Int J Res Pharm Hos & Clin. Pharm, vol. 2, no. 1, pp. 1–4, Sep. 2019, Accessed: Apr. 19, 2025. [Online]. Available: https://rubatosis.org/journals/index.php/ijrhcp/article/view/144